J.P. Bercu
Advertisement
J.P. Bercu is senior director in nonclinical safety and pathobiology, Gilead Sciences.
Articles by J.P. Bercu
Advertisement
Latest Updated Articles
Managing the Risk of Nitrosamine ImpuritiesMarch 15th 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5